Novartis Trims 2020 Sales Forecast on Pandemic Disruption

Bookmark
(Bloomberg) -- Novartis AG trimmed its sales forecast for the year as the pandemic hit demand for the eye drug Lucentis and other medicines.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.